Literature DB >> 20538864

Recessive versus imprinted disorder: consanguinity can impede establishing the diagnosis of autosomal dominant pseudohypoparathyroidism type Ib.

Serap Turan1, Leyla Akin, Teoman Akcay, Erdal Adal, Sevil Sarikaya, Murat Bastepe, Harald Jüppner.   

Abstract

Hypocalcemia and hyperphosphatemia with low/normal parathyroid hormone (PTH) levels can be observed in hypoparathyroidism (HP), a disorder that may follow an autosomal dominant (AD) or autosomal recessive (AR) mode of inheritance. Similar biochemical changes are also observed in pseudohypoparathyroidism (PHP) type Ia and Ib, but affected patients usually show elevated PTH levels indicative of hormonal resistance. Features of Albright's hereditary osteodystrophy (AHO) are typically not observed in patients affected by familial forms of PHP-Ib, which are most frequently caused by maternally inherited, heterozygous microdeletions within STX16 and are associated with isolated loss of methylation at GNAS exon A/B. We established the molecular defect in two children of consanguineous Turkish parents, who presented with hypocalcemia, hyperphosphatemia, and low 25-OH vitamin D levels, but initially normal or only mildly elevated PTH levels, i.e. findings that do not readily exclude HP. After normalizing serum magnesium levels, hypocalcemia and hyperphosphatemia persisted, and PTH levels increased, suggesting PTH resistance rather than PTH deficiency. Because of the absence of AHO and parental consanguinity, an AR form of PHP-Ib appeared plausible, which had previously been suggested for sporadic cases. However, loss of GNAS methylation was restricted to exon A/B, which led to the identification of the 3-kb STX16 microdeletion. The same mutation was also detected in the healthy mother, who did not show any GNAS methylation abnormality, indicating that her deletion resides on the paternal allele. Our findings emphasize the importance of considering a parentally imprinted, AD disorder even if consanguinity suggests an AR mode of inheritance.

Entities:  

Mesh:

Year:  2010        PMID: 20538864      PMCID: PMC2990771          DOI: 10.1530/EJE-10-0348

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  24 in total

1.  Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy.

Authors:  Guiomar Pérez de Nanclares; Eduardo Fernández-Rebollo; Izortze Santin; Beatriz García-Cuartero; Sonia Gaztambide; Edelmiro Menéndez; Maria Jose Morales; Manuel Pombo; José Ramón Bilbao; Francisco Barros; Nuria Zazo; Wiebke Ahrens; Harald Jüppner; Olaf Hiort; Luis Castaño; Murat Bastepe
Journal:  J Clin Endocrinol Metab       Date:  2007-04-03       Impact factor: 5.958

Review 2.  A census of mammalian imprinting.

Authors:  Ian M Morison; Joshua P Ramsay; Hamish G Spencer
Journal:  Trends Genet       Date:  2005-08       Impact factor: 11.639

Review 3.  Different mutations within or upstream of the GNAS locus cause distinct forms of pseudohypoparathyroidism.

Authors:  Harald Jüppner; Murat Bastepe
Journal:  J Pediatr Endocrinol Metab       Date:  2006-05       Impact factor: 1.634

4.  A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS.

Authors:  Agnès Linglart; Robert C Gensure; Robert C Olney; Harald Jüppner; Murat Bastepe
Journal:  Am J Hum Genet       Date:  2005-03-30       Impact factor: 11.025

5.  Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib.

Authors:  Murat Bastepe; Leopold F Fröhlich; Agnès Linglart; Hilal S Abu-Zahra; Katsuyoshi Tojo; Leanne M Ward; Harald Jüppner
Journal:  Nat Genet       Date:  2004-12-12       Impact factor: 38.330

Review 6.  Short stature, obesity, and growth hormone deficiency in pseudohypoparathyroidism type 1a.

Authors:  Emily L Germain-Lee
Journal:  Pediatr Endocrinol Rev       Date:  2006-04

Review 7.  Mutations in the Gs alpha gene causing hormone resistance.

Authors:  Giovanna Mantovani; Anna Spada
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2006-12       Impact factor: 4.690

8.  Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance.

Authors:  Elena Laspa; Murat Bastepe; Harald Jüppner; Agathocles Tsatsoulis
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

9.  Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism.

Authors:  J Baron; K K Winer; J A Yanovski; A W Cunningham; L Laue; D Zimmerman; G B Cutler
Journal:  Hum Mol Genet       Date:  1996-05       Impact factor: 6.150

10.  The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3.

Authors:  H Jüppner; E Schipani; M Bastepe; D E Cole; M L Lawson; M Mannstadt; G N Hendy; H Plotkin; H Koshiyama; T Koh; J D Crawford; B R Olsen; M Vikkula
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

View more
  3 in total

1.  TSH elevations as the first laboratory evidence for pseudohypoparathyroidism type Ib (PHP-Ib).

Authors:  Angelo Molinaro; Dov Tiosano; Rieko Takatani; Dionisios Chrysis; William Russell; Nikolas Koscielniak; Marie-Laure Kottler; Patrizia Agretti; Giuseppina De Marco; Petteri Ahtiainen; Marta Christov; Outi Mäkitie; Massimo Tonacchera; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2015-05       Impact factor: 6.741

2.  De novo STX16 deletions: an infrequent cause of pseudohypoparathyroidism type Ib that should be excluded in sporadic cases.

Authors:  Serap Turan; Jaakko Ignatius; Jukka S Moilanen; Outi Kuismin; Helen Stewart; Nicholas P Mann; Agnès Linglart; Murat Bastepe; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2012-10-18       Impact factor: 5.958

3.  Genetic and reproductive consequences of consanguineous marriage in Bangladesh.

Authors:  Saeed Anwar; Jarin Taslem Mourosi; Yasir Arafat; Mohammad Jakir Hosen
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.